12-21467523-G-GCAAA
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_024854.5(PYROXD1):c.1160_1163dupCAAA(p.Lys388fs) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 31)
Consequence
PYROXD1
NM_024854.5 frameshift
NM_024854.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.81
Genes affected
PYROXD1 (HGNC:26162): (pyridine nucleotide-disulphide oxidoreductase domain 1) This gene encodes a nuclear-cytoplasmic pyridine nucleotide-disulphide reductase (PNDR). PNDRs are flavoproteins that catalyze the pyridine nucleotide-dependent reduction of thiol residues in other proteins. The encoded protein belongs to the class I pyridine nucleotide-disulphide oxidoreductase family but lacks the C-terminal dimerization domain found in other family members and instead has a C-terminal nitrile reductase domain. It localizes to the nucleus and to striated sarcomeric compartments. Naturally occurring mutations in this gene cause early-onset myopathy with internalized nuclei and myofibrillar disorganization. A pseudogene of this gene has been defined on chromosome 11. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-21467523-G-GCAAA is Pathogenic according to our data. Variant chr12-21467523-G-GCAAA is described in ClinVar as [Pathogenic]. Clinvar id is 372282.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PYROXD1 | NM_024854.5 | c.1160_1163dupCAAA | p.Lys388fs | frameshift_variant | 11/12 | ENST00000240651.14 | NP_079130.2 | |
PYROXD1 | NM_001350912.2 | c.947_950dupCAAA | p.Lys317fs | frameshift_variant | 11/12 | NP_001337841.1 | ||
PYROXD1 | NM_001350913.2 | c.383_386dupCAAA | p.Lys129fs | frameshift_variant | 10/11 | NP_001337842.1 | ||
PYROXD1 | XM_017019976.3 | c.416_419dupCAAA | p.Lys140fs | frameshift_variant | 5/6 | XP_016875465.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PYROXD1 | ENST00000240651.14 | c.1160_1163dupCAAA | p.Lys388fs | frameshift_variant | 11/12 | 1 | NM_024854.5 | ENSP00000240651.9 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 29
GnomAD4 exome
Cov.:
29
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Myofibrillar myopathy 8 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 19, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at